Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Keith Batchelder is the founder and CEO of Genomic Healthcare Strategies (GHS), a consultancy focused on the market changes in healthcare resulting from advances in science, technology, and particularly molecular medicine and genomics. GHS provides strategy and implementation services for companies looking to find and enter the new, emerging markets, grow existing markets or transform current business. GHS has worked with pharma/biotechs, diagnostics and the investment community, as well as a widening array of new entrants such as pharmacy benefit managers and wellness companies. At GHS he provides analysis of new markets, channels, partners, and the new science supporting the rapidly evolving practice of medicine and wellness.
His career has spanned medical research, clinical practice, and management in start-ups and large organizations. He has helped raise funding, grow companies and also spin new ventures from parent organizations. His operational experience includes serving as chief technical officer of WorldCare International Clinical Trials, where he used biomarkers as surrogate endpoints for successful FDA approvals; as CIO of Harvard Salud Integral, where he helped to raise funding and grow a start-up HMO in Mexico City; as a principal of AMICAS Corp, where he help develop a Web based radiology system, and at Massachusetts General Hospital for eight years, where he conducted research in drug discovery and published in peer reviewed journals.
Dr. Batchelder was educated at Middlebury College, the Hahnemann University School of Medicine, received postgraduate training in Medical Informatics at The Boston VA Hospital and completed a fellowship at the Food and Drug Administration.
Dr. Batchelder writes and speaks frequently on the topic of personalized medicine (e.g., (Nature Biotechnology, Scientific American conference on Targeted Medicine) and has organized several well attended symposia including one of the first on Personalized Medicine: Breaking Down Barriers and Getting Results in 2007.
Dr. Batchelder is one of the first ten volunteers to have their genomes sequenced and published in Harvard Genetics Professor George Church’s Personal Genome Project.